PGRCX
Price
$57.60
Change
-$0.24 (-0.41%)
Updated
Dec 1 closing price
Net Assets
1.04B
RNPFX
Price
$74.11
Change
-$0.62 (-0.83%)
Updated
Dec 1 closing price
Net Assets
163.52B
Interact to see
Advertisement

PGRCX vs RNPFX

Header iconPGRCX vs RNPFX Comparison
Open Charts PGRCX vs RNPFXBanner chart's image
BNY Mellon Worldwide Growth C
Price$57.60
Change-$0.24 (-0.41%)
VolumeN/A
Net Assets1.04B
American Funds New Perspective R5
Price$74.11
Change-$0.62 (-0.83%)
VolumeN/A
Net Assets163.52B
PGRCX vs RNPFX Comparison Chart in %
View a ticker or compare two or three
VS
PGRCX vs. RNPFX commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRCX is a StrongBuy and RNPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 164B vs. PGRCX (1.04B). RNPFX pays higher dividends than PGRCX: RNPFX (0.69) vs PGRCX (0.00). PGRCX was incepted earlier than RNPFX: PGRCX (30 years) vs RNPFX (24 years). PGRCX (1.89) is less costly to investors than RNPFX (0.46). RNPFX is a more actively managed with annual turnover of: 24.00 vs. PGRCX (13.83). RNPFX has a lower initial minimum investment than PGRCX: RNPFX (250) vs PGRCX (1000). RNPFX annual gain was more profitable for investors over the last year : 12.56 vs. PGRCX (-3.08). RNPFX return over 5 years is better than : 26.46 vs. PGRCX (4.58).
PGRCXRNPFXPGRCX / RNPFX
Total Expense Ratio1.890.46411%
Annual Report Gross Expense Ratio1.890.46411%
Fund Existence30 years24 years-
Gain YTD12.70519.45565%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B164B1%
Annual Yield % from dividends0.000.69-
Returns for 1 year-3.0812.56-25%
Returns for 3 years10.6144.9624%
Returns for 5 years4.5826.4617%
Returns for 10 years20.5894.4022%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKRO54.440.08
+0.15%
Akero Therapeutics
CBRE159.34-2.49
-1.54%
Cbre Group
JVA3.62-0.10
-2.69%
Coffee Holding Co
ETHZ9.45-1.22
-11.47%
ETHZilla Corporation
SUPX25.68-4.45
-14.77%
SuperX AI Technology Limited